Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Metabolic link between obesity and autoimmune diseases

Metabolic link between obesity and autoimmune diseases The abnormal accumulation of visceral adipose tissue in obesity is associated with metabolic changes that include altered glucose tolerance, insulin resistance, hyperlipidemia, and metabolic syndrome. Obesity also coincides with increased incidence of autoimmune diseases. Accumulating evidence suggest that prolonged metabolic overload related to overnutrition, influenced by genetic and epigenetic factors, might affect immunologic self-tolerance through changes in the energy metabolism of immune cells, particularly regulatory T (Treg) cells. A strong activation of nutrient-energy signaling pathways blocks the induction of the transcription factor forkhead P3 (FOXP3), a master regulator of Treg cells, consequently inhibiting their generation and proliferation, thereby promoting proinflammatory response. Expanding our knowledge on the topic, particularly on metabolic T cell flexibility in vivo will provide new insights that can be used to develop therapeutic strategies for various inflammatory diseases, including obesity and autoimmune diseases. Targeting specific metabolic pathways is emerging as an important approach to control immune response and maintain immunological homeostasis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Cytokine Network Springer Journals

Metabolic link between obesity and autoimmune diseases

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/metabolic-link-between-obesity-and-autoimmune-diseases-UwfyuDJw7R
Publisher
Springer Journals
Copyright
Copyright © JLE/Springer 2021
eISSN
1952-4005
DOI
10.1684/ecn.2021.0474
Publisher site
See Article on Publisher Site

Abstract

The abnormal accumulation of visceral adipose tissue in obesity is associated with metabolic changes that include altered glucose tolerance, insulin resistance, hyperlipidemia, and metabolic syndrome. Obesity also coincides with increased incidence of autoimmune diseases. Accumulating evidence suggest that prolonged metabolic overload related to overnutrition, influenced by genetic and epigenetic factors, might affect immunologic self-tolerance through changes in the energy metabolism of immune cells, particularly regulatory T (Treg) cells. A strong activation of nutrient-energy signaling pathways blocks the induction of the transcription factor forkhead P3 (FOXP3), a master regulator of Treg cells, consequently inhibiting their generation and proliferation, thereby promoting proinflammatory response. Expanding our knowledge on the topic, particularly on metabolic T cell flexibility in vivo will provide new insights that can be used to develop therapeutic strategies for various inflammatory diseases, including obesity and autoimmune diseases. Targeting specific metabolic pathways is emerging as an important approach to control immune response and maintain immunological homeostasis.

Journal

European Cytokine Network – Springer Journals

Published: Dec 1, 2021

Keywords: obesity; autoimmunity; immunometabolism; lymphocyte metabolism; cytokines

References

  • The balance of Th17 versus Treg cells in autoimmunity
    Lee, GR
  • Metabolic regulation of T lymphocytes
    MacIver, NJ; Michalek, RD; Rathmell, JC
  • Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases
    Cooper, GS; Bynum, ML; Somers, EC
  • The multiple pathways to autoimmunity
    Theofilopoulos, AN; Kono, DH; Baccala, R
  • The world incidence and prevalence of autoimmune diseases is increasing
    Lerner, A; Jeremias, P; Matthias, T
  • Participants of the 99(th) Dahlem Conference.. Infection, inflammation, and chronic diseases: consequences of a modern lifestyle
    Ehlers, S; Kaufmann, SH
  • The effect of infections on susceptibility to autoimmune and allergic diseases
    Bach, JF
  • Metabolic pressure and the breach of immunological self-tolerance
    De Rosa, V; La Cava, A; Matarese, G
  • Role of “Western diet” in inflammatory autoimmune diseases
    Manzel, A; Muller, DN; Hafler, DA; Erdman, SE; Linker, RA; Kleinewietfeld, M
  • The obesity epidemic — Nature via nurture: a narrative review of high-income countries
    Jackson, SE; Llewellyn, CH; Smith, L
  • Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort
    Harpsøe, MC; Basit, S; Andersson, M
  • Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)
    Gremese, E; Tolusso, B; Gigante, MR; Ferraccioli, G
  • Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study
    Jensen, CB; Ängquist, LH; Mendall, MA; Sørensen, TIA; Baker, JL; Jess, T
  • Connecting type 1 and type 2 diabetes through innate immunity
    Odegaard, JI; Chawla, A
  • Obesity and multiple sclerosis: a Mendelian randomization study
    Mokry, LE; Ross, S; Timpson, NJ; Sawcer, S; Davey Smith, G; Richards, JB
  • Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
    Sterry, W; Strober, BE; Menter, A
  • The clinical biochemistry of obesity
    Sikaris, KA
  • Obesity and inflammation
    Karczewski, J; Sledzinska, E; Baturo, A
  • Adapting to obesity with adipose tissue inflammation
    Reilly, SM; Saltiel, AR
  • Bystander T cells: a balancing act of friends and foes
    Whiteside, SK; Snook, JP; Williams, MA; Weis, JJ
  • Systemic immunometabolism: challenges and opportunities
    Lercher, A; Baazim, H; Bergthaler, A
  • Nutrient-sensing mechanisms and pathways
    Efeyan, A; Comb, WC; Sabatini, DM
  • mTOR signaling in growth, metabolism and disease
    Saxton, RA; Sabatini, DM
  • Regulation and function of mTOR signalling in T cell fate decisions
    Chi, H
  • Cellular metabolism dictates T cell effector function in health and disease
    Kolan, SS; Li, G; Wik, JA
  • The spectrum of T cell metabolism in health and disease
    Bantug, GR; Galluzzi, L; Kroemer, G; Hess, C
  • Normalization of obesity-associated insulin resistance through immunotherapy
    Winer, S; Chan, Y; Paltser, G
  • Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
    Feuerer, M; Herrero, L; Cipolletta, D
  • CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
    Nishimura, S; Manabe, I; Nagasaki, M
  • IL-17 regulates adipogenesis, glucose homeostasis, and obesity
    Zúñiga, LA; Shen, WJ; Joyce-Shaikh, B
  • Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance
    Yang, H; Youm, YH; Vandanmagsar, B
  • The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo
    Blagih, J; Coulombe, F; Vincent, EE
  • Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species
    Stentz, FB; Kitabchi, AE
  • Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia
    Martinez, N; Vallerskog, T; West, K
  • Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells
    Chen, S; Feng, B; George, B; Chakrabarti, R; Chen, M; Chakrabarti, S
  • ATP-citrate lyase is essential for high glucose-induced histone hyperacetylation and fibrogenic gene upregulation in mesangial cells
    Deb, DK; Chen, Y; Sun, J; Wang, Y; Li, YC
  • Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications
    Kennedy, A; Martinez, K; Chuang, CC; LaPoint, K; McIntosh, M
  • Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation
    Eguchi, K; Manabe, I; Oishi-Tanaka, Y
  • Differential regulation of human Treg and Th17 cells by fatty acid synthesis and glycolysis
    Cluxton, D; Petrasca, A; Moran, B; Fletcher, JM
  • Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
    Haghikia, A; Jörg, S; Duscha, A
  • Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1
    Endo, Y; Asou, HK; Matsugae, N
  • Obesity-induced metabolic stress leads to biased effector memory CD4+ T cell differentiation via PI3K p1108-Akt-mediated signals
    Mauro, C; Smith, J; Cucchi, D
  • Regulation of immune cell function by short-chain fatty acids
    Corrêa-Oliveira, R; Fachi, JL; Vieira, A; Sato, FT; Vinolo, MAR
  • The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses
    Clark, RB; Bishop-Bailey, D; Estrada-Hernandez, T; Hla, T; Puddington, L; Padula, SJ
  • Regulatory T cells in obesity: the leptin connection
    Matarese, G; Procaccini, C; De Rosa, V; Horvath, TL; La Cava, A
  • PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
    Cipolletta, D; Feuerer, M; Li, A
  • Characterization of regulatory T cells in obese omental adipose tissue in humans
    Wu, D; Han, JM; Yu, X
  • Visceral adipose tissue Tregs and the cells that nurture them
    Li, C; Spallanzani, RG; Mathis, D
  • The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
    Delgoffe, GM; Pollizzi, KN; Waickman, AT
  • Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses
    Stelzner, K; Herbert, D; Popkova, Y
  • The regulation of immune tolerance by FOXP3
    Lu, L; Barbi, J; Pan, F
  • Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodies
    Daley, SR; Coakley, KM; Hu, DY
  • Adipose tissue-resident immune cells in obesity and type 2 diabetes
    Lu, J; Zhao, J; Meng, H; Zhang, X
  • Metabolic fitness of T cells in autoimmune disease
    Wu, B; Goronzy, JJ; Weyand, CM
  • Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways
    Jacobs, SR; Herman, CE; Maciver, NJ
  • The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function
    Macintyre, AN; Gerriets, VA; Nichols, AG
  • WASH knockout T cells demonstrate defective receptor trafficking, proliferation, and effector function
    Piotrowski, JT; Gomez, TS; Schoon, RA; Mangalam, AK; Billadeau, DD
  • Normalization of CD4+ T cell metabolism reverses lupus
    Yin, Y; Choi, SC; Xu, Z
  • HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
    Shi, LZ; Wang, R; Huang, G
  • The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
    Wang, R; Dillon, CP; Shi, LZ
  • Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets
    Michalek, RD; Gerriets, VA; Jacobs, SR
  • Amino acids and immune function
    Li, P; Yin, YL; Li, D; Kim, SW; Wu, G
  • Amino acid flux and protein synthesis after exposure of rats to either Diplococcus pneumoniae or Salmonella typhimurium
    Wannemacher, RW; Powanda, MC; Dinterman, RE
  • Control of T-cell activation and signaling by amino-acid catabolizing enzymes
    Castellano, F; Molinier-Frenkel, V
  • Halofuginone-induced amino acid starvation regulates Stat3-dependent Th17 effector function and reduces established autoimmune inflammation
    Carlson, TJ; Pellerin, A; Djuretic, IM
  • Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
    Keller, TL; Zocco, D; Sundrud, MS
  • Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response
    Sundrud, MS; Koralov, SB; Feuerer, M
  • Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway
    Saxton, RA; Knockenhauer, KE; Wolfson, RL
  • Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation
    Carr, EL; Kelman, A; Wu, GS
  • System A amino acid transporters regulate glutamine uptake and attenuate antibody-mediated arthritis
    Raposo, B; Vaartjes, D; Ahlqvist, E; Nandakumar, KS; Holmdahl, R
  • Metabolic signaling in T cells
    Shyer, JA; Flavell, RA; Bailis, W
  • Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation
    Nakaya, M; Xiao, Y; Zhou, X
  • Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation
    Ron-Harel, N; Santos, D; Ghergurovich, JM
  • The methotrexate story: a paradigm for development of cancer chemotherapeutic agents
    Huennekens, FM
  • De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
    Berod, L; Friedrich, C; Nandan, A
  • Metabolomics in multiple sclerosis
    Bhargava, P; Calabresi, PA
  • The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
    Youssef, S; Stüve, O; Patarroyo, JC
  • Statins as modulators of regulatory T-cell biology
    Forero-Peña, DA; Gutierrez, FRS
  • Immune modulatory effects of statins
    Zeiser, R
  • Obesity and susceptibility to autoimmune diseases
    Procaccini, C; Carbone, F; Galgani, M
  • The multiple pathways to autoimmunity
    Theofilopoulos, AN; Kono, DH; Baccala, R
  • Obesity-associated autoantibody production requires AIM to retain the immuno-globulin M immune complex on follicular dendritic cells
    Arai, S; Maehara, N; Iwamura, Y
  • B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
    Winer, DA; Winer, S; Shen, L
  • Obesity, fat mass and immune system: role for leptin
    Francisco, V; Pino, J; Campos-Cabaleiro, V
  • Leptin in autoimmune diseases
    Procaccini, C; Pucino, V; Mantzoros, CS; Matarese, G
  • Adipokines and autoimmunity in inflammatory arthritis
    Neumann, E; Hasseli, R; Ohl, S; Lange, U; Frommer, KW; Müller-Ladner, U
  • Individual and stable autoantibody repertoires in healthy individuals
    Neiman, M; Hellström, C; Just, D
  • Interrelation of diet, gut microbiome, and autoantibody production
    Petta, I; Fraussen, J; Somers, V; Kleinewietfeld, M
  • Autoantibody production in obesity: is there evidence for a link between obesity and autoimmunity?
    Tsigalou, C; Vallianou, N; Dalamaga, M
  • B cells in the pathophysiology of myasthenia gravis
    Yi, JS; Guptill, JT; Stathopoulos, P; Nowak, RJ; O’Connor, KC
  • B lymphocytes in neuromyelitis optica
    Bennett, JL; O’Connor, KC; Bar-Or, A
  • New insights into the immunopathogenesis of systemic lupus erythematosus
    Tsokos, GC; Lo, MS; Costa Reis, P; Sullivan, KE
  • Anti-insulin B cells are poised for antigen presentation in type 1 diabetes
    Felton, JL; Maseda, D; Bonami, RH; Hulbert, C; Thomas, JW
  • B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice
    Hulbert, C; Riseili, B; Rojas, M; Thomas, JW
  • Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies
    Meffre, E; O’Connor, KC
  • Obesity in autoimmune diseases: not a passive bystander
    Versini, M; Jeandel, PY; Rosenthal, E; Shoenfeld, Y
  • Identification and characterization of metabolically benign obesity in humans
    Stefan, N; Kantartzis, K; Machann, J
  • Obesity induces pro-inflammatory B cells and impairs B cell function in old mice
    Frasca, D; Diaz, A; Romero, M; Vazquez, T; Blomberg, BB
  • Secretion of autoimmune antibodies in the human subcutaneous adipose tissue
    Frasca, D; Diaz, A; Romero, M; Thaller, S; Blomberg, BB
  • Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development?
    Ferrara, CT; Geyer, SM; Liu, YF
  • The accelerator hypothesis and increasing incidence of type 1 diabetes
    Fourlanos, S; Harrison, LC; Colman, PG
  • The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes
    Fourlanos, S; Varney, MD; Tait, BD